Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate

Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder

(2011) Xavier Castells et al.   CNS DRUGS

Australian National Trends in Stimulant Dispensing: 2002–2009

(2010) Samantha A. Hollingworth et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Rare chromosomal deletions and duplications in attention-deficit hyperactivity disorder: a genome-wide analysis

(2010) Nigel M Williams et al.   LANCET

Sudden Death and Use of Stimulant Medications in Youths

(2009) Madelyn S. Gould et al.   AMERICAN JOURNAL OF PSYCHIATRY

Use of Atomoxetine in Patients with Attention-Deficit Hyperactivity Disorder and Co-Morbid Conditions

(2009) Grazia DellʼAgnello et al.   CNS DRUGS

Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents†

(2009) Karly P. Garnock-Jones et al.   CNS DRUGS

Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

(2009) Stephen V. Faraone et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Atomoxetine

(2009) Karly P. Garnock-Jones et al.   PEDIATRIC DRUGS

Atomoxetine and Osmotically Released Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder: Acute Comparison and Differential Response

(2008) Jeffrey H. Newcorn et al.   AMERICAN JOURNAL OF PSYCHIATRY

Utilization of Pharmacologic Treatment in Youths with Attention Deficit/Hyperactivity Disorder in Medicaid Database

(2007) Almut G Winterstein et al.   ANNALS OF PHARMACOTHERAPY